Useful applications of growth factors for cardiovascular regenerative medicine

References

• Ahmed, M. S., J. Gravning, V. N. Martinov, T. G. von Lueder, T. Edvardsen, G. Czibik, I. T. Moe, et al. 2011. “Mechanisms of Novel Cardioprotective Functions of CCN2/CTGF in Myocardial Ischemia-Reperfusion Injury.” American Journal of Physiology-Heart and Circulatory Physiology 300: 1291–1302. doi:10.1152/ajpheart.00604.2010.
   PubMed Web of Science ®Google Scholar
• Aghila Rani, K. G., and C. C. Kartha. 2010. “Effects of Epidermal Growth Factor on Proliferation and Migration of Cardiosphere-Derived Cells Expanded from Adult Human Heart.” Growth Factors 28 (3): 157–165. doi:10.3109/08977190903512628.
   PubMed Web of Science ®Google Scholar
• Alehagen, U., R. S. Olsen, T. Länne, A. Matussek, and D. Wågsäter. 2016. “PDGF-D Gene Polymorphism is Associated with Increased Cardiovascular Mortality in Elderly Men.” BMC Medical Genetics 17 (1): 62. doi:10.1186/s12881-016-0325-z.
   PubMedGoogle Scholar
• Alexanian, R. A., K. Mahapatra, D. Lang, R. Vaidyanathan, Y. S. Markandeya, R. K. Gill, A. J. Zhai, et al. 2020. “Induced Cardiac Progenitor Cells Repopulate Decellularized Mouse Heart Scaffolds and Differentiate to Generate Cardiac Tissue.” Biochimica et Biophysica Acta. Molecular Cell Research 1867 (3): 118559. doi:10.1016/j.bbamcr.2019.118559.
   PubMed Web of Science ®Google Scholar
• Almahmoud, M. F., E. Z. Soliman, A. G. Bertoni, B. Kestenbaum, R. Katz, J. A. C. Lima, P. Ouyang, P. E. Miller, E. D. Michos, and D. M. Herrington. 2018. “Fibroblast Growth Factor-23 and Heart Failure with Reduced versus Preserved Ejection Fraction: MESA.” Journal of the American Heart Association 7: e008334. doi:10.1161/JAHA.117.008334.
   PubMed Web of Science ®Google Scholar
• Alonso, A., J. R. Misialek, J. H. Eckfeldt, E. Selvin, J. Coresh, L. Y. Chen, E. Z. Soliman, S. K. Agarwal, and P. L. Lutsey. 2014. “Circulating Fibroblast Growth Factor-23 and the Incidence of Atrial Fibrillation: The Atherosclerosis Risk in Communities study.” Journal of the American Heart Association 3 (5): e001082. doi:10.1161/JAHA.114.001082.
   PubMed Web of Science ®Google Scholar
• Amin, A. H., Z. Y. Abd Elmageed, D. Nair, M. I. Partyka, P. J. Kadowitz, S. Belmadani, and K. Matrougui. 2010. “Modified Multipotent Stromal Cells with Epidermal Growth Factor Restore Vasculogenesis and Blood Flow in Ischemic hind-limb of type II diabetic mice .” Laboratory Investigation 90 (7): 985–996. doi:10.1038/labinvest.2010.86.
   PubMed Web of Science ®Google Scholar
• Andrae, J., R. Gallini, and C. Betsholtz. 2008. “Role of Platelet-Derived Growth Factors in Physiology and Medicine.” Genes & Development 22 (10): 1276–1312. doi:10.1101/gad.1653708.
   PubMed Web of Science ®Google Scholar
• Anitua, E., M. Troya, M. Zalduendo, and G. Orive. 2015. “Effects of Anti-Aggregant, Anti-Inflammatory and Anti-Coagulant Drug Consumption on the Preparation and Therapeutic Potential of Plasma Rich in Growth Factors (PRGF).” Growth Factors 33 (1): 57–64. doi:10.3109/08977194.2014.977437.
   PubMed Web of Science ®Google Scholar
• Apte, R. S., D. S. Chen, and N. Ferrara. 2019. “VEGF in Signaling and Disease: Beyond Discovery and Development.” Cell 176 (6): 1248–1264. doi:10.1016/j.cell.2019.01.021.
   PubMed Web of Science ®Google Scholar
• Arakaki, N., S. Kawakami, O. Nakamura, T. Ohnishi, H. Miyazaki, T. Ishii, H. Tsubouchi, et al. 1995. “Evidence for the Presence of an Inactive Precursor of Human Hepatocyte Growth Factor in Plasma and Sera of Patients with Liver Diseases.” Hepatology 22 (6): 1728–1734. doi:10.1016/0270-9139(95)90198-1
   PubMed Web of Science ®Google Scholar
• Arcopinto, M., J. Isgaard, A. M. Marra, P. Formisano, E. Bossone, O. Vriz, C. Vigorito, L. Saccà, P. S. Douglas, and A. Cittadini. 2014. “IGF-1 Predicts Survival in Chronic Heart Failure. Insights from the T.O.S.CA. (Trattamento Ormonale Nello Scompenso Cardiaco) Registry.” International Journal of Cardiology 176 (3): 1006–1008. doi:10.1016/j.ijcard.2014.07.003.
   PubMed Web of Science ®Google Scholar
• Arcopinto, M., A. Salzano, F. Giallauria, E. Bossone, J. Isgaard, A. M. Marra, E. Bobbio, et al. 2017. “Growth Hormone Deficiency is Associated with Worse Cardiac Function, Physical Performance, and Outcome in Chronic Heart Failure: Insights from the T.O.S.CA. GHD Study.” PLoS One 12 (1): e0170058. doi:10.1371/journal.pone.0170058.
   PubMed Web of Science ®Google Scholar
• Badade, P. S., S. A. Mahale, A. A. Panjwani, P. D. Vaidya, and A. D. Warang. 2016. “Antimicrobial Effect of Platelet-Rich Plasma and Platelet-Rich Fibrin.” Indian Journal of Dental Research 27 (3): 300–304. doi:10.4103/0970-9290.186231.
   PubMedGoogle Scholar
• Barrientos, S., O. Stojadinovic, M. S. Golinko, H. Brem, and M. Tomic-Canic. 2008. “Growth Factors and Cytokines in Wound Healing.” Wound Repair and Regeneration 16 (5): 585–601. doi:10.1111/j.1524-475X.2008.00410.x.
   PubMed Web of Science ®Google Scholar
• Barroso, M. C., F. Kramer, S. J. Greene, D. Scheyer, T. Köhler, M. Karoff, M. Seyfarth, M. Gheorghiade, and W. Dinh. 2016. “Serum Insulin-like Growth Factor-1 and Its Binding Protein-7: Potential Novel Biomarkers for Heart Failure with Preserved Ejection Fraction.” BMC Cardiovascular Disorders 16: 199. doi:10.1186/s12872-016-0376-2.
   PubMed Web of Science ®Google Scholar
• Behnes, M., M. Brueckmann, S. Lang, C. Weiß, P. Ahmad-Nejad, M. Neumaier, M. Borggrefe, and U. Hoffmann. 2014. “Connective Tissue Growth Factor (CTGF/CCN2): Diagnostic and Prognostic Value in Acute Heart Failure.” Clinical Research in Cardiology 103 (2): 107–116. doi:10.1007/s00392-013-0626-6.
   PubMed Web of Science ®Google Scholar
• Behnes, M., U. Hoffmann, S. Lang, C. Weiss, P. Ahmad-Nejad, M. Neumaier, M. Borggrefe, and M. Brueckmann. 2011. “Transforming Growth Factor Beta 1 (TGF-Beta 1) in Atrial Fibrillation and Acute Congestive Heart Failure.” Clinical Research in Cardiology 100 (4): 335–342. doi:10.1007/s00392-010-0248-1.
   PubMed Web of Science ®Google Scholar
• Bell, E. J., P. A. Decker, M. Y. Tsai, J. S. Pankow, N. Q. Hanson, C. L. Wassel, N. B. Larson, et al. 2018. “Hepatocyte Growth Factor is Associated with Progression of Atherosclerosis: The Multi-Ethnic Study of Atherosclerosis (MESA).” Atherosclerosis 272: 162–167. doi:10.1016/j.atherosclerosis.2018.03.040.
   PubMed Web of Science ®Google Scholar
• Benjamin, E. J., S. S. Virani, C. W. Callaway, A. M. Chamberlain, A. R. Chang, S. Cheng, S. E. Chiuve, et al. 2018. “Heart Disease and Stroke Statistics-2018 Update: A Report from the American Heart Association.” Circulation 137 (12): e67–e492. doi:10.1161/CIR.0000000000000558.
   PubMed Web of Science ®Google Scholar
• Bergmark, B. A., J. A. Udell, D. A. Morrow, C. P. Cannon, D. L. Steen, P. Jarolim, A. Budaj, et al. 2018. “Association of Fibroblast Growth Factor 23 with Recurrent Cardiovascular Events in Patients after an Acute Coronary Syndrome: A Secondary Analysis of a Randomized Clinical Trial.” JAMA Cardiology 3 (6): 473–480. doi:10.1001/jamacardio.2018.0653.
   PubMed Web of Science ®Google Scholar
• Berntsson, J., J. G. Smith, L. S. B. Johnson, M. Söderholm, Y. Borné, O. Melander, M. Orho-Melander, J. Nilsson, and G. Engström. 2019. “Increased Vascular Endothelial Growth Factor D is Associated with Atrial Fibrillation and Ischemic Stroke.” Heart (British Cardiac Society) 105 (7): 553–558. doi:10.1136/heartjnl-2018-313684.
   PubMed Web of Science ®Google Scholar
• Bhandari, S. S., H. Narayan, D. J. Jones, T. Suzuki, J. Struck, A. Bergmann, I. B. Squire, and L. L. Ng. 2016. “Plasma Growth Hormone is a Strong Predictor of Risk at 1 Year in Acute Heart Failure.” European Journal of Heart Failure 18 (3): 281–289. doi:10.1002/ejhf.459.
   PubMed Web of Science ®Google Scholar
• Bielinski, S. J., C. Berardi, P. A. Decker, N. B. Larson, E. J. Bell, J. S. Pankow, M. M. Sale, et al. 2017. “Hepatocyte Growth Factor Demonstrates Racial Heterogeneity as a Biomarker for Coronary Heart Disease.” Heart 103 (15): 1185–1193. doi:10.1136/heartjnl-2016-310450.
   PubMed Web of Science ®Google Scholar
• Blau, H. M., and G. Q. Daley. 2019. “Stem Cells in the Treatment of Disease.” The New England Journal of Medicine 380 (18): 1748–1760. doi:10.1056/NEJMra1716145.
   PubMed Web of Science ®Google Scholar
• Brea, M. S., R. G. Díaz, D. S. Escudero, C. I. Caldiz, E. L. Portiansky, P. E. Morgan, and N. G. Pérez. 2016. “Epidermal Growth Factor Receptor Silencing Blunts the Slow Force Response to Myocardial Stretch.” Journal of the American Heart Association 5: e004017. doi:10.1161/JAHA.116.004017.
   PubMed Web of Science ®Google Scholar
• Bruno, G., F. Cencetti, I. Pertici, L. Japtok, C. Bernacchioni, C. Donati, and P. Bruni. 2015. “CTGF/CCN2 Exerts Profibrotic Action in Myoblasts via the up-Regulation of Sphingosine Kinase-1/S1P3 Signaling Axis: Implications in the Action Mechanism of TGFβ.” Biochimica et Biophysica Acta 1851 (2): 194–202. doi:10.1016/j.bbalip.2014.11.011.
   PubMed Web of Science ®Google Scholar
• Čapek, D., and P. Müller. 2019. “Positional Information and Tissue Scaling during Development and Regeneration.” Development 146 (24): 146. doi:10.1242/dev.177709.
   Web of Science ®Google Scholar
• Carotenuto, F., L. Teodori, A. M. Maccari, L. Delbono, G. Orlando, and P. Di Nardo. 2019. “Turning Regenerative Technologies into Treatment to Repair Myocardial Injuries.” Journal of Cellular and Molecular Medicine doi:10.1111/jcmm.14630..
   PubMed Web of Science ®Google Scholar
• Castellano, G., F. Affuso, P. D. Conza, and S. Fazio. 2009. “The GH/IGF-1 Axis and Heart Failure.” Current Cardiology Reviews 5 (3): 203–215. doi:10.2174/157340309788970306.
   PubMedGoogle Scholar
• Ceccarelli, S., P. Pontecorvi, E. Anastasiadou, C. Napoli, and C. Marchese. 2020. “Immunomodulatory Effect of Adipose-Derived Stem Cells: The Cutting Edge of Clinical Application.” Frontiers in Cell and Developmental Biology 8: 1–12. doi:10.3389/fcell.2020.00236.
   PubMed Web of Science ®Google Scholar
• Chaudhary, N. I., G. J. Roth, F. Hilberg, J. Müller-Quernheim, A. Prasse, G. Zissel, A. Schnapp, and J. E. Park. 2007. “Inhibition of PDGF, VEGF and FGF Signaling Attenuates Fibrosis.” The European Respiratory Journal 29 (5): 976–985. doi:10.1183/09031936.00152106.
   PubMed Web of Science ®Google Scholar
• Chen, X. G., Y. X. Lv, D. Zhao, L. Zhang, F. Zheng, J. Y. Yang, X. L. Li, et al. 2016. “Vascular Endothelial Growth factor-C Protects Heart from Ischemia/Reperfusion Injury by Inhibiting Cardiomyocyte Apoptosis.” Molecular and Cellular Biochemistry 413 (1–2): 9–23. doi:10.1007/s11010-015-2622-9.
   PubMed Web of Science ®Google Scholar
• Chen, B., Z. Tao, Y. Zhao, H. Chen, Y. Yong, X. Liu, H. Wang, Z. Wu, Z. Yang, and L. Yuan. 2013. “Catheter-Based Intramyocardial Delivery (NavX) of Adenovirus Achieves Safe and Accurate Gene Transfer in Pigs.” PLoS One 8 (1): e53007. doi:10.1371/journal.pone.0053007.
   PubMed Web of Science ®Google Scholar
• Chung, C.-C., Y.-K. Lin, Y.-C. Chen, Y.-H. Kao, T.-I. Lee, and Y.-J. Chen. 2020. “Vascular Endothelial Growth Factor Enhances Profibrotic Activities through Modulation of Calcium Homeostasis in Human Atrial Fibroblasts.” Laboratory Investigation; a Journal of Technical Methods and Pathology 100 (2): 285–296. doi:10.1038/s41374-019-0341-7.
   PubMed Web of Science ®Google Scholar
• Chi, H., H. Feng, X. Shang, J. Jiao, L. Sun, W. Jiang, X. Meng, et al. 2019. “Circulating Connective Tissue Growth Factor is Associated with Diastolic Dysfunction in Patients with Diastolic Heart Failure.” Cardiology 143 (3–4): 77–84. doi:10.1159/000499179.
   PubMed Web of Science ®Google Scholar
• Cho, N., S. E. Razipour, and M. L. McCain. 2018. “Featured Article: TGF-β1 Dominates Extracellular Matrix Rigidity for Inducing Differentiation of Human Cardiac Fibroblasts to Myofibroblasts.” Experimental Biology and Medicine 243 (7): 601–612. doi:10.1177/1535370218761628.
   Web of Science ®Google Scholar
• Cieślik-Bielecka, A., T. Bold, G. Ziółkowski, M. Pierchała, A. Królikowska, and P. Reichert. 2018. “Antibacterial Activity of Leukocyte- and Platelet-Rich Plasma: An in Vitro Study.” BioMed Research International 2018: 9471723. doi:10.1155/2018/9471723.
   PubMed Web of Science ®Google Scholar
• Cittadini, A., A. M. Marra, M. Arcopinto, E. Bobbio, A. Salzano, D. Sirico, R. Napoli, et al. 2013. “Growth Hormone Replacement Delays the Progression of Chronic Heart Failure Combined with Growth Hormone Deficiency: An Extension of a Randomized Controlled Single-Blind Study.” JACC: Heart Failure 1 (4): 325–330. doi:10.1016/j.jchf.2013.04.003.
   PubMed Web of Science ®Google Scholar
• Costa, D., G. Benincasa, R. Lucchese, T. Infante, G. F. Nicoletti, and C. Napoli. 2019. “Effect of Nitric Oxide Reduction on Arterial thrombosis.” Scandinavian Cardiovascular Journal 53 (1): 1–8. doi:10.1080/14017431.2019.1581943.
   PubMed Web of Science ®Google Scholar
• Cossu, G., R. Fears, G. Griffin, and V. Ter Meulen. 2020. “Regenerative Medicine: Challenges and Opportunities.” Lancet 395 (10239): 1746–1747. doi:10.1016/S0140-6736(20)31250-2.
   PubMed Web of Science ®Google Scholar
• D’Elia, E., A. Pascale, N. Marchesi, P. Ferrero, M. Senni, S. Govoni, E. Gronda, and E. Vanoli. 2014. “Novel Approaches to the Post-Myocardial Infarction/Heart Failure Neural Remodeling.” Heart Failure Reviews 19 (5): 611–619. doi:10.1007/s10741-013-9415-6.
   PubMed Web of Science ®Google Scholar
• Dashkevich, A., C. Hagl, F. Beyersdorf, A. I. Nykänen, and K. B. Lemström. 2016. “VEGF Pathways in the Lymphatics of Healthy and Diseased Heart.” Microcirculation 23 (1): 5–14. doi:10.1111/micc.12220.
   PubMed Web of Science ®Google Scholar
• De Giusti, V. C., M. B. Nolly, A. M. Yeves, C. I. Caldiz, M. C. Villa-Abrille, G. E. Chiappe de Cingolani, I. L. Ennis, H. E. Cingolani, and E. A. Aiello. 2011. “Aldosterone Stimulates the Cardiac Na+/H+ Exchanger via Transactivation of the Epidermal Growth Factor Receptor.” Hypertension 58 (5): 912–919. doi:10.1161/HYPERTENSIONAHA.111.176024.
   PubMedGoogle Scholar
• De Pascale, M. R., L. Sommese, A. Casamassimi, and C. Napoli. 2015. “Platelet Derivatives in Regenerative Medicine: An Update.” Transfusion Medicine Reviews 29 (1): 52–61. doi:10.1016/j.tmrv.2014.11.001.
   PubMed Web of Science ®Google Scholar
• Deo, R., R. Katz, I. H. de Boer, N. Sotoodehnia, B. Kestenbaum, K. J. Mukamal, M. Chonchol, et al. 2015. “Fibroblast Growth Factor 23 and Sudden versus Non-Sudden Cardiac Death: The Cardiovascular Health Study.” American Journal of Kidney Diseases 66 (1): 40–46. doi:10.1053/j.ajkd.2014.10.025.
   PubMed Web of Science ®Google Scholar
• Derangeon, M., J. Montnach, C. O. Cerpa, B. Jagu, J. Patin, G. Toumaniantz, A. Girardeau, et al. 2017. “Transforming Growth Factor β Receptor Inhibition Prevents Ventricular Fibrosis in a Mouse Model of Progressive Cardiac Conduction Disease.” Cardiovascular Research 113 (5): 464–474. doi:10.1093/cvr/cvx026.
   PubMed Web of Science ®Google Scholar
• Dreux, A. C., D. J. Lamb, H. Modjtahedi, and G. A. Ferns. 2006. “The Epidermal Growth Factor Receptors and Their Family of Ligands: Their Putative Role in Atherogenesis.” Atherosclerosis 186 (1): 38–53. doi:10.1016/j.atherosclerosis.2005.06.038.
   PubMed Web of Science ®Google Scholar
• Dronkers, E., A. T. Moerkamp, T. van Herwaarden, M. J. Goumans, and A. M. Smits. 2018. “The Isolation and Culture of Primary Epicardial Cells Derived from Human Adult and Fetal Heart Specimens.” Journal of Visualized Experiments 24 (134): 57370. doi:10.3791/57370.
   PubMed Web of Science ®Google Scholar
• Działo, E., K. Tkacz, and P. Błyszczuk. 2018. “Crosstalk between the TGF-β and WNT Signaling Pathways during Cardiac Fibrogenesis.” Acta Biochimica Polonica 65 (3): 341–349. doi:10.18388/abp.2018_2635.
   PubMed Web of Science ®Google Scholar
• Eswarakumar, V. P., I. Lax, and J. Schlessinger. 2005. “Cellular Signaling by Fibroblast Growth Factor Receptors.” Cytokine & Growth Factor Reviews 16 (2): 139–149. doi:10.1016/j.cytogfr.2005.01.001.
   PubMed Web of Science ®Google Scholar
• Favaloro, L., M. Diez, O. Mendiz, G. V. Janavel, L. Valdivieso, R. Ratto, G. Garelli, et al. 2013. “A Phase I, Open-Label, Two-Year Follow-up Trial.” Catheterization and Cardiovascular Interventions 82 (6): 899–906. doi:10.1002/ccd.24555.
   PubMed Web of Science ®Google Scholar
• Faul, C. 2017. “Cardiac Actions of Fibroblast Growth Factor 23.” Bone 100: 69–79. doi:10.1016/j.bone.2016.10.001.
   PubMed Web of Science ®Google Scholar
• Faul, C., A. P. Amaral, B. Oskouei, M.-C. Hu, A. Sloan, T. Isakova, O. M. Gutiérrez, et al. 2011. “FGF23 Induces Left Ventricular Hypertrophy.” The Journal of Clinical Investigation 121 (11): 4393–4408. doi:10.1172/JCI46122.
   PubMed Web of Science ®Google Scholar
• Fernández-Colino, A., L. Iop, M. S. Ventura Ferreira, and P. Mela. 2019. “Fibrosis in Tissue Engineering and Regenerative Medicine: Treat or Trigger?” Advanced Drug Delivery Reviews 146: 17–36. doi:10.1016/j.addr.2019.07.007.
   PubMed Web of Science ®Google Scholar
• Ferrara, N., and A. Adamis. 2016. “Ten Years of anti-Vascular Endothelial Growth Factor Therapy.” Nature Reviews. Drug Discovery 15 (6): 385–403. doi:10.1038/nrd.2015.17.
   PubMed Web of Science ®Google Scholar
• Folestad, E., A. Kunath, and D. Wågsäter. 2018. “PDGF-C and PDGF-D Signaling in Vascular Diseases and Animal Models.” Molecular Aspects of Medicine 62: 1–11. doi:10.1016/j.mam.2018.01.005.
   PubMed Web of Science ®Google Scholar
• Formica, F., P. Perseghin, A. Cirò, and G. Paolini. 2014. “Late Driveline Left Ventricular Assist Device Infection Treated with Frozen-and-Thawed Allogeneic Platelet Gel.” Interactive Cardiovascular and Thoracic Surgery 19 (3): 523–525. doi:10.1093/icvts/ivu195.
   PubMed Web of Science ®Google Scholar
• Freedman, S. B., and J. M. Isner. 2001. “Therapeutic Angiogenesis for Ischemic Cardiovascular Disease.” Journal of Molecular and Cellular Cardiology 33 (3): 379–393. doi:10.1006/jmcc.2000.1329.
   PubMed Web of Science ®Google Scholar
• Fukushima, T., S. Uchiyama, H. Tanaka, and H. Kataoka. 2018. “Hepatocyte Growth Factor Activator: A Proteinase Linking Tissue Injury with Repair.” International Journal of Molecular Sciences 19 (11): 3435. doi:10.3390/ijms19113435.
   Web of Science ®Google Scholar
• Gallini, R., P. Lindblom, C. Bondjers, C. Betsholtz, and J. Andrae. 2016. “PDGF-A and PDGF-B Induces Cardiac Fibrosis in Transgenic Mice.” Experimental Cell Research 349 (2): 282–290. doi:10.1016/j.yexcr.2016.10.022.
   PubMed Web of Science ®Google Scholar
• Gallo, S., V. Sala, S. Gatti, and T. Crepaldi. 2015. “Cellular and Molecular Mechanisms of HGF/Met in the Cardiovascular System.” Clinical Science 129 (12): 1173–1193. doi:10.1042/CS20150502.
   PubMed Web of Science ®Google Scholar
• Gao, J., J. Liu, Y. Gao, C. Wang, Y. Zhao, B. Chen, Z. Xiao, et al. 2011. “A Myocardial Patch Made of Collagen Membranes Loaded with Collagen-Binding Human Vascular Endothelial Growth Factor Accelerates Healing of the Injured Rabbit Heart.” Tissue Engineering. Part A 17 (21–22): 2739–2747. doi:10.1089/ten.TEA.2011.0105.
   PubMed Web of Science ®Google Scholar
• Gekle, M., R. Freudinger, S. Mildenberger, and S. Silbernagl. 2002. “Rapid Actions of Aldosterone on Cells from Renal Epithelium: The Possible Role of EGF-Receptor Signaling.” Steroids 67 (6): 499–504. doi:10.1016/S0039-128X(01)00183-0.
   PubMed Web of Science ®Google Scholar
• Glazer, N. L., E. M. Macy, T. Lumley, N. L. Smith, A. P. Reiner, B. M. Psaty, G. L. King, et al. 2012. “Transforming Growth Factor Beta-1 and Incidence of Heart Failure in Older Adults: The Cardiovascular Health Study.” Cytokine 60 (2): 341–345. doi:10.1016/j.cyto.2012.07.013.
   PubMed Web of Science ®Google Scholar
• Golebiewska, E. M., and A. W. Poole. 2015. “Platelet Secretion: From Haemostasis to Wound Healing and beyond.” Blood Reviews 29 (3): 153–162. doi:10.1016/j.blre.2014.10.003.
   PubMed Web of Science ®Google Scholar
• Govoni, S., A. Pascale, M. Amadio, L. Calvillo, E. D’Elia, C. Cereda, P. Fantucci, M. Ceroni, and E. Vanoli. 2011. “NGF and Heart: Is There a Role in Heart Disease?” Pharmacological Research 63 (4): 266–277. doi:10.1016/j.phrs.2010.12.017.
   PubMed Web of Science ®Google Scholar
• Gramley, F., J. Lorenzen, E. Koellensperger, K. Kettering, C. Weiss, and T. Munzel. 2010. “Atrial Fibrosis and Atrial Fibrillation: The Role of the TGF-β1 Signaling Pathway.” International Journal of Cardiology 143 (3): 405–413. doi:10.1016/j.ijcard.2009.03.110.
   PubMed Web of Science ®Google Scholar
• Gravning, J., S. Ørn, O. J. Kaasbøll, V. N. Martinov, C. Manhenke, K. Dickstein, T. Edvardsen, et al. 2012. “Myocardial Connective Tissue Growth Factor (CCN2/CTGF) Attenuates Left Ventricular Remodeling after Myocardial Infarction.” 7 (12): e52120. doi:10.1371/journal.pone.0052120.
   Google Scholar
• Grimaldi, V., A. Zullo, F. Donatelli, F. P. Mancini, F. Cacciatore, and C. Napoli. 2018. “Potential Clinical Benefits of Cell Therapy in Coronary Heart Disease: An Update.” Journal of Thoracic Disease 10 (S20): S2412–S2422. doi:10.21037/jtd.2018.04.149.
   PubMedGoogle Scholar
• Gronda, E., S. Sacchi, G. Benincasa, E. Vanoli, and C. Napoli. 2019. “Unresolved Issues in Left Ventricular Postischemic Remodeling and Progression to Heart failure.” Journal of Cardiovascular Medicine 20 (10): 640–649. doi:10.2459/JCM.0000000000000834.
   PubMed Web of Science ®Google Scholar
• Gronda, E., E. Vanoli, S. Sacchi, G. Grassi, G. Ambrosio, and C. Napoli. 2019. “Risk of Heart Failure Progression in Patients with Reduced Ejection Fraction: Mechanisms and Therapeutic Options.” Heart Failure Reviews 25: 295–303. doi:10.1007/s10741-019-09823-z..
   Web of Science ®Google Scholar
• Hanna, A., and N. G. Frangogiannis. 2019. “The Role of the TGF-β Superfamily in Myocardial Infarction.” Frontiers in Cardiovascular Medicine 6: 140. doi:10.3389/fcvm.2019.00140.
   PubMed Web of Science ®Google Scholar
• Hao, H., X. Li, Q. Li, H. Lin, Z. Chen, J. Xie, W. Xuan, et al. 2016. “FGF23 Promotes Myocardial Fibrosis in Mice through Activation of β-catenin.” Oncotarget 7 (40): 64649–64664. doi:10.18632/oncotarget.11623.
   PubMedGoogle Scholar
• Hartikainen, J., I. Hassinen, A. Hedman, A. Kivelä, A. Saraste, J. Knuuti, M. Husso, et al. 2017. “Adenoviral Intramyocardial VEGF-DΔNΔC Gene Transfer Increases Myocardial Perfusion Reserve in Refractory Angina Patients: A Phase I/IIa Study with 1-Year Follow-up.” European Heart Journal 38 (33): 2547–2555. doi:10.1093/eurheartj/ehx352.
   PubMed Web of Science ®Google Scholar
• He, B., X. Yuan, A. Zhou, H. Zhang, and D. Jiang. 2014. “Designer Functionalized Self-Assembling Peptide Nanofibre Scaffolds for Cartilage Tissue Engineering.” Expert Reviews in Molecular Medicine 16: e12. doi:10.1017/erm.2014.13.
   PubMed Web of Science ®Google Scholar
• Heldin, C. H., and A. Moustakas. 2016. “Signaling Receptors for TGF-β Family Members.” Cold Spring Harbor Perspectives in Biology 8 (8): a022053. doi:10.1101/cshperspect.a022053.
   PubMed Web of Science ®Google Scholar
• Henning, R. J. 2016. “Therapeutic Angiogenesis: Angiogenic Growth Factors for Ischemic Heart disease.” Future Cardiology 12 (5): 585–599. doi:10.2217/fca-2016-0006.
   PubMed Web of Science ®Google Scholar
• Huang, G., and D. R. Brigstock. 2012. “Regulation of Hepatic Stellate Cells by Connective Tissue Growth Factor.” Frontiers in Bioscience 17: 2495–2507. doi:10.2741/4067.
   PubMed Web of Science ®Google Scholar
• Imazu, M., H. Takahama, H. Asanuma, A. Funada, Y. Sugano, T. Ohara, T. Hasegawa, et al. 2014. “Pathophysiological Impact of Serum Fibroblast Growth Factor 23 in Patients with Nonischemic Cardiac Disease and Early Chronic Kidney Disease.” American Journal of Physiology-Heart and Circulatory Physiology 307: 1504–1511. doi:10.1152/ajpheart.00331.2014.
   Web of Science ®Google Scholar
• Isgaard, J., M. Arcopinto, K. Karason, and A. Cittadini. 2015. “GH and the Cardiovascular System: An Update on a Topic at Heart.” Endocrine (1)48: 25–35. doi:10.1007/s12020-014-0327-6.
   PubMed Web of Science ®Google Scholar
• Itoh, N., and H. Ohta. 2013. “Pathophysiological Roles of FGF Signaling in the Heart.” Frontiers in Physiology 4: 247. doi:10.3389/fphys.2013.00247.
   PubMed Web of Science ®Google Scholar
• Itoh, N., H. Ohta, Y. Nakayama, and M. Konishi. 2016. “Roles of FGF Signals in Heart Development, Health, and Disease.” Frontiers in Cell and Developmental Biology 4: 110 doi:10.3389/fcell.2016.00110.
   PubMed Web of Science ®Google Scholar
• Iwamoto, R., and E. Mekada. 2006. “ErbB and HB-EGF Signaling in Heart Development and Function.” Cell Structure and Function 31 (1): 1–14. doi:10.1247/csf.31.1.
   PubMed Web of Science ®Google Scholar
• Jiang, Z. S., R. R. Padua, H. Ju, B. W. Doble, Y. Jin, J. Hao, et al. 2002. “Acute Protection of Ischemic Heart by FGF-2: Involvement of FGF-2 Receptors and Protein Kinase C.” American Journal of Physiology-Heart and Circulatory Physiology 282: 1071–1080.
   PubMed Web of Science ®Google Scholar
• Jiang, Z., G. Zhong, L. Wen, Y. Hong, S. Fang, P. Sun, S. Li, et al. 2016. “The Role of Platelet-Derived Growth factor-B/Platelet-Derived Growth Factor Receptor-β Signaling in Chronic Atrial Fibrillation.” Cardiology 133 (4): 242–256. doi:10.1159/000442940.
   PubMed Web of Science ®Google Scholar
• Karlowatz, R.-J., J. Scharhag, J. Rahnenführer, U. Schneider, E. Jakob, W. Kindermann, K. D. Zang, et al. 2011. “Polymorphisms in the IGF1 Signaling Pathway Including the Myostatin Gene Are Associated with Left Ventricular Mass in Male Athletes.” British Journal of Sports Medicine 45 (1): 36–41. doi:10.1136/bjsm.2008.050567.
   PubMed Web of Science ®Google Scholar
• Karu, I., J. Starkopf, K. Zilmer, and M. Zilmer. 2013. “Growth Factors Serum Levels in Coronary Artery Disease Patients Scheduled for Bypass Surgery: Perioperative Dynamics and Comparisons with Healthy Volunteers.” BioMed Research International 2013: 985404. doi:10.1155/2013/985404.
   PubMed Web of Science ®Google Scholar
• Katoh, M., and H. Nakagama. 2014. “FGF Receptors: Cancer Biology and Therapeutics.” Medicinal Research Reviews 34 (2): 280–300. doi:10.1002/med.21288.
   PubMed Web of Science ®Google Scholar
• Kestenbaum, B., M. C. Sachs, A. N. Hoofnagle, D. S. Siscovick, J. H. Ix, C. Robinson-Cohen, J. A. C. Lima, et al. 2014. “Fibroblast Growth Factor-23 and Cardiovascular Disease in the General Population: The Multi-Ethnic Study of Atherosclerosis.” Circulation. Heart Failure 7 (3): 409–417. doi:10.1161/CIRCHEARTFAILURE.113.000952.
   PubMed Web of Science ®Google Scholar
• Khan, R. S., M. D. Martinez, J. C. Sy, K. D. Pendergrass, P.-l. Che, M. E. Brown, E. B. Cabigas, et al. 2014. “Targeting Extracellular DNA to Deliver IGF-1 to the Injured Heart.” Scientific Reports 4: 4257. doi:10.1038/srep04257.
   PubMed Web of Science ®Google Scholar
• Kim, J.-S., I.-G. Choi, B.-C. Lee, J.-B Park, J.-H. Kim, J. H. Jeong, J. H. Jeong, et al. 2012. “Neuregulin Induces CTGF Expression in Hypertrophic Scarring Fibroblasts.” Molecular and Cellular Biochemistry 365 (1–2): 181–189. doi:10.1007/s11010-012-1258-2.
   PubMed Web of Science ®Google Scholar
• Kim, J., J. Kim, S. H. Lee, S. V. Kepreotis, J. Yoo, J.-S. Chun, R. J. Hajjar, et al. 2016. “Park Cytokine-Like 1 Regulates Cardiac Fibrosis via Modulation of TGF-β Signaling.” PLoS One 11 (11): e0166480. doi:10.1371/journal.pone.0166480.
   PubMed Web of Science ®Google Scholar
• Kirmani, B. H., S. G. Jones, S. Datta, E. K. Mclaughlin, and A. J. Hoschtitzky. 2017. “A Meta-Analysis of Platelet Gel for Prevention of Sternal Wound Infections Following Cardiac Surgery.” Blood Transfusion 15 (1): 57–65. doi:10.2450/2016.0231-15.
   PubMed Web of Science ®Google Scholar
• Kitamura, N., K. Miyazawa, Y. Uehara, M. Komada, A. Okajima, M. Okigaki, and A. Kitamura. 1995. “Gene Expression and Regulation of HGF-SF.” EXS 65: 49–65.
   Google Scholar
• Kofidis, T., J. L. de Bruin, G. Hoyt, D. R. Lebl, M. Tanaka, T. Yamane, C.-P. Chang, et al. 2004. “Injectable Bioartificial Myocardial Tissue for Large-Scale Intramural Cell Transfer and Functional Recovery of Injured Heart Muscle.” The Journal of Thoracic and Cardiovascular Surgery 128 (4): 571–578. doi:10.1016/j.jtcvs.2004.05.021.
   PubMed Web of Science ®Google Scholar
• Kokkinos, J., S. Tang, K. A. Rye, and K. L. Ong. 2017. “The Role of Fibroblast Growth Factor 21 in Atherosclerosis.” Atherosclerosis 257: 259–265. doi:10.1016/j.atherosclerosis.2016.11.033.
   PubMed Web of Science ®Google Scholar
• Koller, L., M. E. Kleber, V. M. Brandenburg, G. Goliasch, B. Richter, P. Sulzgruber, H. Scharnagl, et al. 2015. “Fibroblast Growth Factor 23 is an Independent and Specific Predictor of Mortality in Patients with Heart Failure and Reduced Ejection Fraction.” Circulation: Heart Failure 8 (6): 1059–1067. doi:10.1161/CIRCHEARTFAILURE.115.002341.
   PubMed Web of Science ®Google Scholar
• Komarowska, I., D. Coe, G. Wang, R. Haas, C. Mauro, M. Kishore, D. Cooper, et al. 2015. “Hepatocyte Growth Factor Receptor c-Met Instructs T Cell Cardiotropism and Promotes T Cell Migration to the Heart via Autocrine Chemokine Release.” Immunity 42 (6): 1087–1099. doi:10.1016/j.immuni.2015.05.014.
   PubMed Web of Science ®Google Scholar
• Koshman, Y. E., N. Patel, M. Chu, R. Iyengar, T. Kim, C. Ersahin, W. Lewis, et al. 2013. “Regulation of Connective Tissue Growth Factor Gene Expression and Fibrosis in Human Heart Failure.” Journal of Cardiac Failure 19 (4): 283–294. doi:10.1016/j.cardfail.2013.01.013.
   PubMed Web of Science ®Google Scholar
• Krug, A. W., C. Grossmann, C. Schuster, R. Freudinger, S. Mildenberger, M. V. Govindan, and M. Gekle. 2003. “Aldosterone Stimulates Epidermal Growth Factor Receptor Expression.” The Journal of Biological Chemistry 278 (44): 43060–43066. doi:10.1074/jbc.M308134200.
   PubMed Web of Science ®Google Scholar
• Lakshmanan, R., P. Kumaraswamy, U. M. Krishnan, and S. Sethuraman. 2016. “Engineering a Growth Factor Embedded Nanofiber Matrix Niche to Promote Vascularization for Functional Cardiac Regeneration.” Biomaterials 97: 176–195. doi:10.1016/j.biomaterials2016.02.033.
   PubMed Web of Science ®Google Scholar
• Lamblin, N., A. Bauters, M. Fertin, P. de Groote, F. Pinet, and C. Bauters. 2011. “Circulating Levels of Hepatocyte Growth Factor and Left Ventricular Remodeling after Acute Myocardial Infarction (from the REVE-2 Study).” European Journal of Heart Failure 13 (12): 1314–1322. doi:10.1093/eurjhf/hfr137.
   PubMed Web of Science ®Google Scholar
• Larson, N. B., C. Berardi, Paul A. Decker, C. L. Wassel, P. S. Kirsch, J. S. Pankow, M. M. Sale, et al. 2015. “Trans-Ethnic Meta-Analysis Identifies Common and Rare Variants Associated with Hepatocyte Growth Factor Levels in the Multi-Ethnic Study of Atherosclerosis (MESA).” Annals of Human Genetics 79 (4): 264–274. doi:10.1111/ahg.12119.
   PubMed Web of Science ®Google Scholar
• Lee, C., and X. Li. 2018. “Platelet-Derived Growth factor-C and -D in the Cardiovascular System and Diseases.” Molecular Aspects of Medicine 62: 12–21. doi:10.1016/j.mam.2017.09.005.
   PubMed Web of Science ®Google Scholar
• Lewis, F. C., S. D. Kumar, and G. M. Ellison-Hughes. 2018. “Non-Invasive Strategies for Stimulating Endogenous Repair and Regenerative Mechanisms in the Damaged Heart.” Pharmacological Research 127: 33–40. doi:10.1016/j.phrs.2017.08.016.
   PubMed Web of Science ®Google Scholar
• Levi-Montalcini, R., S. D. Skaper, R. Dal Toso, L. Petrelli, and A. Leon. 1996. “Nerve Growth Factor: From Neurotrophin to Neurokine.” Trends in Neurosciences 19 (11): 514–520. doi:10.1016/S0166-2236(96)10058-8.
   PubMed Web of Science ®Google Scholar
• Lian, H., Y. Ma, J. Feng, W. Dong, Q. Yang, D. Lu, and L. Zhang. 2012. “Heparin-Binding EGF-like Growth Factor Induces Heart Interstitial Fibrosis via an Akt/mTor/p70s6k Pathway.” PLoS One 7 (9): e44946. doi:10.1371/journal.pone.0044946.
   PubMed Web of Science ®Google Scholar
• Li, Y., Z. Jian, Z. Y. Yang, L. Chen, X. F. Wang, R. Y. Ma, and Y. B. Xiao. 2013. “Increased Expression of Connective Tissue Growth Factor and Transforming Growth Factor-Beta-1 in Atrial Myocardium of Patients with Chronic Atrial Fibrillation.” Cardiology 124 (4): 233–240. doi:10.1159/000347126.
   PubMed Web of Science ®Google Scholar
• Lipson, K. E., C. Wong, Y. Teng, and S. Spong. 2012. “CTGF is a Central Mediator of Tissue Remodeling and Fibrosis and Its Inhibition Can Reverse the Process of Fibrosis.” Fibrogenesis & Tissue Repair 5 (S1): 24. doi:10.1186/1755-1536-5-S1-S24.
   PubMedGoogle Scholar
• Li, G., L. Tang, P. Jia, J. Zhao, D. Liu, and B. Liu. 2016. “Elevated Plasma Connective Tissue Growth Factor Levels in Children with Pulmonary Arterial Hypertension Associated with Congenital Heart Disease.” Pediatric Cardiology 37 (4): 714–721. doi:10.1007/s00246-015-1335-x.
   PubMed Web of Science ®Google Scholar
• Liu, G., L. Li, D. Huo, Y. Li, Y. Wu, L. Zeng, P. Cheng, et al. 2017. “A VEGF Delivery System Targeting MI Improves Angiogenesis and Cardiac Function Based on the Tropism of MSCs and Layer-By-Layer Self-Assembly.” Biomaterials 127: 117–131. doi:10.1016/j.biomaterials.2017.03.001.
   PubMed Web of Science ®Google Scholar
• Liu, D., J. Song, X. Ji, Z. Liu, M. Cong, and B. Hu. 2016. “Association of Genetic Polymorphisms on VEGFA and VEGFR2 with Risk of Coronary Heart Disease.” Medicine, 95: e3413. doi:10.1097/MD.0000000000003413.
   PubMed Web of Science ®Google Scholar
• Locatelli, V., and V. E. Bianchi. 2014. “Effect of GH/IGF-1 on Bone Metabolism and Osteoporsosis.” International Journal of Endocrinology 2014: 235060. doi:10.1155/2014/235060.
   PubMed Web of Science ®Google Scholar
• Locatelli, P., F. D. Olea, A. Hnatiuk, A. De Lorenzi, M. Cerdá, C. S. Giménez, D. Sepúlveda, et al. 2015. “Mesenchymal Stromal Cells Overexpressing Vascular Endothelial Growth Factor in Ovine Myocardial infarction.” Gene Therapy 22 (6): 449–457. doi:10.1038/gt.2015.28.
   PubMed Web of Science ®Google Scholar
• Lv, Y.-X., S. Zhong, H. Tang, B. Luo, S.-J. Chen, L. Chen, F. Zheng, et al. 2018. “VEGF-A and VEGF-B Coordinate the Arteriogenesis to Repair the Infarcted Heart with Vagus Nerve Stimulation.” Cellular Physiology and Biochemistry: International Journal of Experimental Cellular Physiology, Biochemistry, and Pharmacology 48 (2): 433–449. doi:10.1159/000491775.
   PubMedGoogle Scholar
• Lutsey, P. L., A. Alonso, E. Selvin, J. S. Pankow, E. D. Michos, S. K. Agarwal, et al. 2014. “Fibroblast Growth Factor-23 and Incident Coronary Heart Disease, Heart Failure, and Cardiovascular Mortality: The Atherosclerosis Risk in Communities Study.” Journal of the American Heart Association 3: e000936. doi:10.1161/JAHA.114.000936.
   PubMed Web of Science ®Google Scholar
• Ma, J., and G. Jin. 2019. “Epidermal Growth Factor Protects against Myocardial Ischemia Reperfusion Injury through Activating Nrf2 Signaling Pathway.” Free Radical Research 53 (3): 313–323. doi:10.1080/10715762.2019.1584399.
   PubMed Web of Science ®Google Scholar
• Madonna, R., C. Cevik, M. Nasser, and R. De Caterina. 2012. “Hepatocyte Growth Factor: Molecular Biomarker and Player in Cardioprotection and Cardiovascular Regeneration.” Thrombosis and Haemostasis 107 (4): 656–661. doi:10.1160/TH11-10-0711.
   PubMed Web of Science ®Google Scholar
• Mahmoud, A. I., C. C. O’Meara, M. Gemberling, L. Zhao, D. M. Bryant, R. Zheng, J. B. Gannon, et al. 2015. “Nerves Regulate Cardiomyocyte Proliferation and Heart Regeneration.” Developmental Cell 34 (4): 387–399. doi:10.1016/j.devcel.2015.06.017.
   PubMed Web of Science ®Google Scholar
• Makarevich, P. I., K. V. Dergilev, Z. I. Tsokolaeva, M. A. Boldyreva, E. K. Shevchenko, E. V. Gluhanyuk, J. O. Gallinger, et al. 2018. “Angiogenic and Pleiotropic Effects of VEGF165 and HGF Combined Gene Therapy in a Rat Model of Myocardial Infarction.” PLoS One 13 (5): e0197566. doi:10.1371/journal.pone.0197566.
   PubMed Web of Science ®Google Scholar
• Makki, N., K. W. Thiel, and F. J. Miller, Jr. 2013. “The Epidermal Growth Factor Receptor and Its Ligands in Cardiovascular disease.” International Journal of Molecular Sciences 14 (10): 20597–20613. doi:10.3390/ijms141020597.
   PubMed Web of Science ®Google Scholar
• Mallone, A., B. Weber, and S. P. Hoerstrup. 2016. “Cardiovascular Regenerative Technologies: Update and Future Outlook.” Transfusion Medicine and Hemotherapy 43 (4): 291–296. doi:10.1159/000447749.
   PubMed Web of Science ®Google Scholar
• Mamer, S. B., S. Chen, J. C. Weddell, A. Palasz, A. Wittenkeller, M. Kumar, and P. I. Imoukhuede. 2017. “Discovery of High-Affinity PDGF-VEGFR Interactions: Redefining RTK Dynamics.” Scientific Reports 7 (1): 16439. doi:10.1038/s41598-017-16610-z.
   PubMedGoogle Scholar
• Marks, E. C. A., T. M. Wilkinson, C. M. Frampton, L. Skelton, A. P. Pilbrow, T. G. Yandle, et al. 2018. “Plasma Levels of Soluble VEGF Receptor Isoforms, Circulating Pterins and VEGF System SNPs as Prognostic Biomarkers in Patients with Acute Coronary Syndromes.” BMC Cardiovascular Disorders 18: 169. doi:10.1186/s12872-018-0894-1.
   PubMed Web of Science ®Google Scholar
• Marneros, A. G. 2018. “Effects of Chronically Increased VEGF-A on the Aging heart.” FASEB Journal 32 (3): 1550–1565. doi:10.1096/fj.201700761RR.
   PubMed Web of Science ®Google Scholar
• Mathew, J. S., M. C. Sachs, R. Katz, K. K. Patton, S. R. Heckbert, A. N. Hoofnagle, A. Alonso, et al. 2014. “Fibroblast Growth Factor-23 and Incident Atrial Fibrillation: The Multi-Ethnic Study of Atherosclerosis (MESA) and the Cardiovascular Health Study (CHS).” Circulation 130 (4): 298–307. doi:10.1161/CIRCULATIONAHA.113.005499.
   PubMed Web of Science ®Google Scholar
• Matsumoto, K., H. Funakoshi, H. Takahashi, and K. Sakai. 2014. “HGF-Met Pathway in Regeneration and Drug Discovery.” Biomedicines 2 (4): 275–300. doi:10.3390/biomedicines2040275.
   PubMedGoogle Scholar
• Mavroudis, C. D., D. Seung Kim, N. Burnham, A. H. Morss, J. H. Kim, A. A. Burt, D. R. Crosslin, et al. 2018. “A Vascular Endothelial Growth Factor a Genetic Variant is Associated with Improved Ventricular Function and Transplant-Free Survival after Surgery for Non-Syndromic CHD.” Cardiology in the Young 28 (1): 39–45. doi:10.1017/S1047951117001391.
   PubMed Web of Science ®Google Scholar
• Medamana, J., R. A. Clark, and J. Butler. 2017. “Platelet-Derived Growth Factor in Heart Failure.” Handbook of Experimental Pharmacology 243: 355–369. doi:10.1007/164_2016_80.
   PubMedGoogle Scholar
• Meloni, M., A. Caporali, G. Graiani, C. Lagrasta, R. Katare, S. Van Linthout, F. Spillmann, et al. 2010. “Nerve Growth Factor Promotes Cardiac Repair following Myocardial Infarction.” Circulation Research 106 (7): 1275–1284. doi:10.1161/CIRCRESAHA.109.210088.
   PubMed Web of Science ®Google Scholar
• Meloni, M., D. Cesselli, A. Caporali, G. Mangialardi, E. Avolio, C. Reni, O. Fortunato, et al. 2015. “Cardiac Nerve Growth Factor Overexpression Induces Bone Marrow-Derived Progenitor Cells Mobilization and Homing to the Infarcted Heart.” Molecular Therapy: The Journal of the American Society of Gene Therapy 23 (12): 1854–1866. doi:10.1038/mt.2015.167.
   PubMed Web of Science ®Google Scholar
• Meloni, M., B. Descamps, A. Caporali, L. Zentilin, I. Floris, M. Giacca, and C. Emanueli. 2012. “Nerve Growth Factor Gene Therapy Using Adeno-Associated Viral Vectors Prevents Cardiomyopathy in Type 1 Diabetic Mice.” Diabetes 61 (1): 229–240. doi:10.2337/db11-0763.
   PubMed Web of Science ®Google Scholar
• Miao, J., S. Huang, Y. R. Su, C. A. Lenneman, M. Wright, F. E. Harrell, D. B. Sawyer, et al. 2018. “Effects of Endogenous Serum Neuregulin-1β on Morbidity and Mortality in Patients with Heart Failure and Left Ventricular Systolic Dysfunction.” Biomarkers: Biochemical Indicators of Exposure, Response, and Susceptibility to Chemicals 23 (7): 704–708. doi:10.1080/1354750X.2018.1485054.
   PubMed Web of Science ®Google Scholar
• Miceli, M., D. Baldi, C. Cavaliere, A. Soricelli, M. Salvatore, and C. Napoli. 2019. “Peripheral Artery Disease: The New Frontiers of Imaging Techniques to Evaluate the Evolution of Regenerative Medicine.” Expert Review of Cardiovascular Therapy 17 (7): 511–532. doi:10.1080/14779072.2019.
   PubMed Web of Science ®Google Scholar
• Mindur, J. E., and F. K. Swirski. 2019. “Growth Factors as Immunotherapeutic Targets in Cardiovascular Disease.” Arteriosclerosis, Thrombosis, and Vascular Biology 39 (7): 1275–1287. doi:10.1161/ATVBAHA.119.311994.
   PubMed Web of Science ®Google Scholar
• Mishra, A., J. Velotta, T. J. Brinton, X. Wang, S. Chang, O. Palmer, A. Sheikh, et al. 2011. “RevaTen Platelet-Rich Plasma Improves Cardiac Function after Myocardial Injury.” Cardiovascular Revascularization Medicine: Including Molecular Interventions 12 (3): 158–163. doi:10.1016/j.carrev.2010.08.005.
   PubMedGoogle Scholar
• Munk, M., A. A. Memon, J. P. Goetze, L. B. Nielsen, E. Nexo, and B. S. Sorensen. 2012. “Hypoxia Changes the Expression of the Epidermal Growth Factor (EGF) System in Human Hearts and Cultured Cardiomyocytes.” PLoS One 7 (7): e40243. doi:10.1371/journal.pone.0040243.
   PubMed Web of Science ®Google Scholar
• Mochizuki, M., G. D. Verde, H. Soliman, O. Pfister, and G. M. Kuster. 2019. “Induction of Endothelial Differentiation in Cardiac Progenitor Cells under Low Serum Conditions.” Journal of Visualized Experiments. Advanced online publication. doi:10.3791/58370..
   PubMed Web of Science ®Google Scholar
• Mogan, C., and D. F. Larson. 2004. “Rationale of Platelet Gel to Augment Adaptive Remodeling of the Injured Heart.” The Journal of Extra-Corporeal Technology 36 (2): 191–196.
   PubMedGoogle Scholar
• Mohamed, R., Y. Cao, R. Afroz, S. Xu, H. T. Ta, M. Barras, W. Zheng, et al. 2020. “ROS Directly Activates Transforming Growth Factor β Type 1 Receptor Signaling in Human Vascular Smooth Muscle cells.” Biochimica et Biophysica Acta – General Subjects 1864 (1): 129463. doi:10.1016/j.bbagen.2019.129463.
   PubMed Web of Science ®Google Scholar
• Morikawa, M., R. Derynck, and K. Miyazono. 2016. “TGF-β and the TGF-β Family: Context-Dependent Roles in Cell and Tissue Physiology.” Cold Spring Harbor Perspectives in Biology 8 (5): a021873. doi:10.1101/cshperspect.a021873.
   PubMed Web of Science ®Google Scholar
• Morine, K. J., X. Qiao, V. Paruchuri, M. J. Aronovitz, E. E. Mackey, L. Buiten, J. Levine, et al. 2017. “Reduced Activin Receptor-like Kinase 1 Activity Promotes Cardiac Fibrosis in Heart failure.” Cardiovascular Pathology 31: 26–33. doi:10.1016/j.carpath.2017.07.004.
   PubMed Web of Science ®Google Scholar
• Morine, K. J., X. Qiao, S. York, P. S. Natov, V. Paruchuri, Y. Zhang, M. J. Aronovitz, et al. 2018. “Bone Morphogenetic Protein 9 Reduces Cardiac Fibrosis and Improves Cardiac Function in Heart Failure.” Circulation 138 (5): 513–526. doi:10.1161/CIRCULATIONAHA.117.031635.
   PubMed Web of Science ®Google Scholar
• Morris, D. R., J. V. Moxon, E. Biros, S. M. Krishna, and J. Golledge. 2012. “Meta-Analysis of the Association between Transforming Growth Factor-Beta Polymorphisms and Complications of Coronary Heart Disease.” PLoS One 7 (5): e37878. doi:10.1371/journal.pone.0037878.
   PubMed Web of Science ®Google Scholar
• Mostaço-Guidolin, L., N. L. Rosin, and T. L. Hackett. 2017. “Imaging Collagen in Scar Tissue: Developments in Second Harmonic Generation Microscopy for Biomedical Applications.” International Journal of Molecular Sciences 18 (8): 1772. doi:10.3390/ijms18081772.
   Web of Science ®Google Scholar
• Napoli, C., G. Benincasa, F. Donatelli, and G. Ambrosio. 2020. “Precision Medicine in Distinct Heart Failure Phenotypes: Focus on Clinical epigenetics.” American Heart Journal 224: 113–128. doi:10.1016/j.ahj.2020.03.007.
   PubMed Web of Science ®Google Scholar
• Napoli, C., and F. Cacciatore. 2009. “Novel Pathogenic Insights in the Primary Prevention of Cardiovascular Disease.” Progress in Cardiovascular Diseases 51 (6): 503–523. doi:10.1016/j.pcad.2009.01.003.
   PubMed Web of Science ®Google Scholar
• Napoli, C., F. de Nigris, S. Williams-Ignarro, O. Pignalosa, V. Sica, and L. J. Ignarro. 2006. “Nitric Oxide and Atherosclerosis: An Update.” Nitric Oxide: Biology and Chemistry 15 (4): 265–279. doi:10.1016/j.niox.2006.03.011.
   PubMed Web of Science ®Google Scholar
• Ni, X., C. Ou, J. Guo, B. Liu, J. Zhang, Z. Wu, H. Li, et al. 2017. “Lentiviral Vector-Mediated Co-Overexpression of VEGF and Bcl-2 Improves Mesenchymal Stem Cell Survival and Enhances Paracrine Effects in Vitro.” International Journal of Molecular Medicine 40 (2): 418–426. doi:10.3892/ijmm.2017.3019.
   PubMed Web of Science ®Google Scholar
• Niu, H., J. Mu, J. Zhang, P. Hu, P. Bo, and Y. Wang. 2013. “Comparative Study of Three Types of Polymer Materials co-Cultured with Bone Marrow Mesenchymal Stem Cells for Use as a Myocardial Patch in Cardiomyocyte Regeneration.” Journal of Materials Science Materials in Medicine 24 (6): 1535–1542. doi:10.1007/s10856-012-4842-9.
   PubMed Web of Science ®Google Scholar
• Normand, C., D. M. Kaye, T. J. Povsic, and K. Dickstein. 2019. “Beyond Pharmacological Treatment: An Insight into Therapies That Target Specific Aspects of Heart Failure Pathophysiology.” Lancet 393 (10175): 1045–1055. doi:10.1016/S0140-6736(18)32216-5.
   PubMed Web of Science ®Google Scholar
• Oduk, Y., W. Zhu, R. Kannappan, M. Zhao, A. V. Borovjagin, S. Oparil, and J. J. Zhang. 2018. “VEGF Nanoparticles Repair the Heart after Myocardial Infarction.” American Journal of Physiology-Heart and Circulatory Physiology 314: 278–284. doi:10.1152/ajpheart.00471.2017.
   Web of Science ®Google Scholar
• Pantou, M. P., A. Manginas, P. A. Alivizatos, and D. Degiannis. 2012. “Connective Tissue Growth Factor (CTGF/CCN2): A Protagonist in Cardiac Allograft Vasculopathy Development?” The Journal of Heart and Lung Transplantation 31 (8): 881–887. doi:10.1016/j.healun.2012.02.034.
   PubMed Web of Science ®Google Scholar
• Papagianni, A. 2017. “Fibroblast Growth Factor-23: A Novel Biomarker for Cardiovascular Disease in Chronic Kidney Disease Patients.” Prilozi (Makedonska Akademija na Naukite i Umetnostite. Oddelenie za Medicinski Nauki) 38 (2): 19–27. doi:10.1515/prilozi-2017-0018.
   PubMedGoogle Scholar
• Peiró, Ó. M., Á. García-Osuna, J. Ordóñez-Llanos, G. Cediel, G. Bonet, S. Rojas, V. Quintern, and A. Bardají. 2019. “Long-Term Prognostic Value of Growth Differentiation Factor-15 in Acute Coronary Syndromes.” Clinical Biochemistry 73: 62–69. doi:10.1016/j.clinbiochem.2019.07.014.
   PubMed Web of Science ®Google Scholar
• Pérez-Calvo, J.-I., J.-L. Morales-Rull, J.-A. Gimeno-Orna, P. Lasierra-Díaz, C. Josa-Laorden, J.-J. Puente-Lanzarote, P. Bettencourt, et al. 2016. “Usefulness of the Hepatocyte Growth Factor as a Predictor of Mortality in Patients Hospitalized with Acute Heart Failure Regardless of Ejection Fraction.” The American Journal of Cardiology 118 (4): 543–549. doi:10.1016/j.amjcard.2016.05.048.
   PubMed Web of Science ®Google Scholar
• Phelps, E. A., and A. J. Garcia. 2009. “Update on Therapeutic Vascularization Strategies.” Regenerative Medicine 4 (1): 65–80. doi:10.2217/17460751.4.1.65.
   PubMed Web of Science ®Google Scholar
• Pikuła, M., P. Langa, P. Kosikowska, and P. Trzonkowski. 2015. “Stem cells and growth factors in wound healing.” Postepy Higieny i Medycyny Doswiadczalnej 69: 874–885. doi:10.5604/17322693.1162989.
   Web of Science ®Google Scholar
• Poppe, A., P. Golsong, B. Blumenthal, R. von Wattenwyl, P. Blanke, F. Beyersdorf, C. Schlensak, et al. 2012. “Hepatocyte Growth Factor-Transfected Skeletal Myoblasts to Limit the Development of Postinfarction Heart Failure.” Artificial Organs 36 (3): 238–246. doi:10.1111/j.1525-1594.2011.01328.x.
   PubMed Web of Science ®Google Scholar
• Rabbani, S., M. Soleimani, M. Sahebjam, M. Imani, A. Haeri, A. Ghiaseddin, et al. 2018. “Simultaneous Delivery of Wharton’s Jelly Mesenchymal Stem Cells and Insulin-like Growth Factor-1 in Acute Myocardial Infarction.” Iranian Journal of Pharmaceutical Research 17: 426–441.
   PubMed Web of Science ®Google Scholar
• Ramazani, Y., N. Knops, M. A. Elmonem, T. Q. Nguyen, F. O. Arcolino, L. van den Heuvel, E. Levtchenko, D. Kuypers, and R. Goldschmeding. 2018. “Connective Tissue Growth Factor (CTGF) from Basics to Clinics.” Matrix Biology: Journal of the International Society for Matrix Biology 68–69: 44–66. doi:10.1016/j.matbio.2018.03.007.
   PubMed Web of Science ®Google Scholar
• Rebouças, J. S., N. S. Santos-Magalhães, and F. R. Formiga. 2016. “Cardiac Regeneration Using Growth Factors: Advances and Challenges.” Arquivos Brasileiros de Cardiologia 107 (3): 271–275. doi:10.5935/abc.20160097.
   PubMed Web of Science ®Google Scholar
• Regouski, M., O. Galenko, J. Doleac, A. L. Olsen, V. Jacobs, and D. Liechty. 2019. “Spontaneous Atrial Fibrillation in Transgenic Goats with TGF (Transforming Growth Factor)-β1 Induced Atrial Myopathy with Endurance Exercise.” Circulation: Arrhythmia and Electrophysiology 12 (11): e007499. doi:10.1161/CIRCEP.119.007499.
   PubMed Web of Science ®Google Scholar
• Reichelt, M. E., S. O’Brien, W. G. Thomas, and J. P. Headrick. 2017. “Transactivation of the Epidermal Growth Factor Receptor in Responses to Myocardial Stress and Cardioprotection.” The International Journal of Biochemistry & Cell Biology 83: 97–110. doi:10.1016/j.biocel.2016.12.014.
   PubMed Web of Science ®Google Scholar
• Reindl, M., S. J. Reinstadler, H.-J. Feistritzer, L. Mueller, C. Koch, A. Mayr, M. Theurl, et al. 2017. “Fibroblast Growth Factor 23 as Novel Biomarker for Early Risk Stratification after ST-Elevation Myocardial Infarction.” Heart 103 (11): 856–862. doi:10.1136/heartjnl-2016-310520.
   PubMed Web of Science ®Google Scholar
• Reuter, M. S., R. Jobling, R. R. Chaturvedi, R. Manshaei, G. Costain, T. Heung, M. Curtis, et al. 2019. “Haploinsufficiency of Vascular Endothelial Growth Factor Related Signaling Genes is Associated with Tetralogy of Fallot.” Genetics in Medicine 21 (4): 1001–1007. doi:10.1038/s41436-018-0260-9.
   PubMed Web of Science ®Google Scholar
• Rychli, K., B. Richter, P. J. Hohensinner, K. Mahdy Ali, S. Neuhold, G. Zorn, R. Berger, et al. 2011. “Hepatocyte Growth Factor is a Strong Predictor of Mortality in Patients with Advanced Heart Failure.” Heart 97 (14): 1158–1163. doi:10.1136/hrt.2010.220228.
   PubMed Web of Science ®Google Scholar
• Rodness, J., A. Mihic, Y. Miyagi, J. Wu, R. D. Weisel, and R. K. Li. 2016. “VEGF-Loaded Microsphere Patch for Local Protein Delivery to the Ischemic Heart.” Acta Biomaterialia 45: 169–181. doi:10.1016/j.actbio.2016.09.009.
   PubMed Web of Science ®Google Scholar
• Rosin, N. L., A. Falkenham, M. J. Sopel, T. D. Lee, and J. F. Légaré. 2013. “Regulation and Role of Connective Tissue Growth Factor in AngII-Induced Myocardial Fibrosis.” American Journal of Pathology 182 (3): 714–726. doi:10.1016/j.ajpath.2012.11.014.
   PubMed Web of Science ®Google Scholar
• Ross, Jr., J. 1999. “Growth Hormone, Cardiomyocyte Contractile Reserve, and Heart Failure.” Circulation 99: 15–17.
   PubMed Web of Science ®Google Scholar
• Rufaihah, A. J., N. A. Johari, S. R. Vaibavi, M. Plotkin, D. T. Di Thien, T. Kofidis, and D. Seliktar. 2017. “Dual Delivery of VEGF and ANG-1 in Ischemic Hearts Using an Injectable Hydrogel.” Acta Biomaterialia 48: 58–67. doi:10.1016/j.actbio.2016.10.013.
   PubMed Web of Science ®Google Scholar
• Sakaguchi, A., C. Nishiyama, and W. Kimura. 2020. “Cardiac Regeneration as an Environmental Adaptation.” Biochimica et Biophysica Acta. Molecular Cell Research 1867 (4): 118623. doi:10.1016/j.bbamcr.2019.118623.
   PubMed Web of Science ®Google Scholar
• Sala, V., and T. Crepaldi. 2011. “Novel Therapy for Myocardial Infarction: Can HGF/Met be Beneficial?” Cellular and Molecular Life Sciences 68 (10): 1703–1717. doi:10.1007/s00018-011-0633-6.
   PubMed Web of Science ®Google Scholar
• Salzano, A., A. M. Marra, R. D’Assante, M. Arcopinto, T. Suzuki, E. Bossone, and A. Cittadini. 2018. “Growth Hormone Therapy in Heart Failure.” Heart Failure Clinics 14 (4): 501–515. doi:10.1016/j.hfc.2018.05.002.
   PubMed Web of Science ®Google Scholar
• Sánchez-Vizcaíno, E., C. Vehí, G. Campreciós, C. Morcillo, M. Soley, and I. Ramírez. 2010. “Heparin-Binding EGF-Like Growth Factor in Human Serum. Association with High Blood Cholesterol and Heart Hypertrophy.” Growth Factors 28 (2): 98–103. doi:10.3109/08977190903443030.
   PubMed Web of Science ®Google Scholar
• Scialla, J. J., H. Xie, M. Rahman, A. H. Anderson, T. Isakova, A. Ojo, X. Zhang, et al. 2014. “Fibroblast Growth Factor-23 and Cardiovascular Events in CKD.” Journal of the American Society of Nephrology 25 (2): 349–360. doi:10.1681/ASN.2013050465.
   PubMed Web of Science ®Google Scholar
• Sewanan, L. R., J. Schwan, J. Kluger, J. Park, D. L. Jacoby, Y. Qyang, and S. G. Campbell. 2019. “Extracellular Matrix from Hypertrophic Myocardium Provokes Impaired Twitch Dynamics in Healthy Cardiomyocytes.” JACC. Basic to Translational Science 4 (4): 495–505. doi:10.1016/j.jacbts.2019.03.004.
   PubMedGoogle Scholar
• Shen, D., J. Tang, M. T. Hensley, T. Li, T. G. Caranasos, T. Zhang, J. Zhang, and K. Cheng. 2016. “Effects of Matrix Metalloproteinases on the Performance of Platelet Fibrin Gel Spiked with Cardiac Stem Cells in Heart Repair.” Stem Cells Translational Medicine 5 (6): 793–803. doi:10.5966/sctm.2015-0194.
   PubMed Web of Science ®Google Scholar
• Shen, H., J. Wang, J. Min, W. Xi, Y. Gao, L. Yin, Y. Yu, et al. 2018. “Activation of TGF-β1/α-SMA/Col I Profibrotic Pathway in Fibroblasts by Galectin-3 Contributes to Atrial Fibrosis in Experimental Models and Patients.” Cellular Physiology and Biochemistry: International Journal of Experimental Cellular Physiology, Biochemistry, and Pharmacology 47 (2): 851–863. doi:10.1159/000490077.
   PubMedGoogle Scholar
• Siltanen, A., K. Kitabayashi, P. Lakkisto, J. Mäkelä, T. Pätilä, M. Ono, I. Tikkanen, et al. 2011. “hHGF Overexpression in Myoblast Sheets Enhances Their Angiogenic Potential in Rat Chronic Heart Failure.” PLoS One 6 (4): e19161. doi:10.1371/journal.pone.0019161.
   PubMed Web of Science ®Google Scholar
• Sommese, L., A. Zullo, C. Schiano, F. P. Mancini, and C. Napoli. 2017. “Possible Muscle Repair in the Human Cardiovascular System.” Stem Cell Reviews and Reports 13 (2): 170–191. doi:10.1007/s12015-016-9711-3.
   PubMed Web of Science ®Google Scholar
• Sonnenberg, S. B., A. A. Rane, C. J. Liu, N. Rao, G. Agmon, S. Suarez, R. Wang, et al. 2015. “Delivery of an Engineered HGF Fragment in an Extracellular Matrix-Derived Hydrogel Prevents Negative LV Remodeling Post-Myocardial Infarction.” Biomaterials 45: 56–63. doi:10.1016/j.biomaterials.2014.12.021.
   PubMed Web of Science ®Google Scholar
• Srisakuldee, W., B. E. Nickel, R. R. Fandrich, Z. S. Jiang, and E. Kardami. 2006. “Administration of FGF-2 to the Heart Stimulates Connexin-43 Phosphorylation at Protein Kinase C Target Sites.” Cell Communication & Adhesion 13 (1–2): 13–19. doi:10.1080/15419060600631326.
   PubMed Web of Science ®Google Scholar
• Sun, L.-Y., X. Qu, L.-Z. Chen, X.-X. Chen, G.-S. Zheng, Z.-T. Wang, W.-J. Huang, et al. 2017. “Molecular Weight Fibroblast Growth Factor-2 as a Promising Prognostic Biomarker to Predict the Occurrence of Heart Failure in Atrial Fibrillation Patients.” Heart and Vessels 32 (12): 1506–1512. doi:10.1007/s00380-017-1019-y.
   PubMed Web of Science ®Google Scholar
• Taimeh, Z., J. Loughran, E. J. Birks, and R. Bolli. 2013. “Vascular Endothelial Growth Factor in Heart Failure.” Nature Reviews. Cardiology 10 (9): 519–530. doi:10.1038/nrcardio.2013.94.
   PubMed Web of Science ®Google Scholar
• Tanai, E., and S. Frantz. 2015. “Pathophysiology of Heart Failure.” Comprehensive Physiology 6 (1): 187–214. doi:10.1002/cphy.c140055.
   PubMed Web of Science ®Google Scholar
• Tanner, M. A., T. P. Thomas, and L. A. Grisanti. 2019. “Death Receptor 5 Contributes to Cardiomyocyte Hypertrophy through Epidermal Growth Factor Receptor Transactivation.” Journal of Molecular and Cellular Cardiology 136: 1–14. doi:10.1016/j.yjmcc.2019.08.011.
   PubMed Web of Science ®Google Scholar
• ter Maaten, J. M., A. A. Voors, K. Damman, P. van der Meer, S. D. Anker, J. G. Cleland, K. Dickstein, et al. 2018. “Fibroblast Growth Factor 23 is Related to Profiles Indicating Volume Overload, Poor Therapy Optimization and Prognosis in Patients with New-Onset and Worsening Heart Failure.” International Journal of Cardiology 253: 84–90. doi:10.1016/j.ijcard.2017.10.010.
   PubMed Web of Science ®Google Scholar
• Thanigaimani, S., D. H. Lau, T. Agbaedeng, A. D. Elliott, R. Mahajan, and P. Sanders. 2017. “Molecular Mechanisms of Atrial Fibrosis: Implications for the Clinic.” Expert Review of Cardiovascular Therapy 15 (4): 247–256. doi:10.1080/14779072.2017.1299005.
   PubMed Web of Science ®Google Scholar
• Tian, Y., Y. Wang, W. Chen, Y. Yin, and M. Qin. 2017. “Role of Serum TGF-β1 Level in Atrial Fibrosis and Outcome after Catheter Ablation for Paroxysmal Atrial Fibrillation.” Medicine 96 (51): e9210. doi:10.1097/MD.0000000000009210.
   PubMed Web of Science ®Google Scholar
• Troncoso, R., C. Ibarra, J. M. Vicencio, E. Jaimovich, and S. Lavandero. 2014. “New Insights into IGF-1 Signaling in the Heart.” Trends in Endocrinology & Metabolism 25 (3): 128–137. doi:10.1016/j.tem.2013.12.002.
   PubMed Web of Science ®Google Scholar
• Tsioumpekou, M., S. I. Cunha, H. Ma, A. Åhgren, J. Cedervall, A. Olsson, C. Heldin, et al. 2020. “Specific Targeting of PDGFRβ in the Stroma Inhibits Growth and Angiogenesis in Tumors with High PDGF-BB Expression.” Theranostics 10 (3): 1122–1135. doi:10.7150/thno.37851.
   PubMed Web of Science ®Google Scholar
• Tuñón, J., B. Fernández-Fernández, R. Carda, A. M. Pello, C. Cristóbal, N. Tarín, Á. Aceña, et al. 2016. “Circulating Fibroblast Growth Factor-23 Plasma Levels Predict Adverse Cardiovascular Outcomes in Patients with Diabetes Mellitus with Coronary Artery Disease.” Diabetes/Metabolism Research and Reviews 32 (7): 685–693. doi:10.1002/dmrr.2787.
   PubMed Web of Science ®Google Scholar
• Tsoutsman, T., X. Wang, K. Garchow, B. Riser, S. Twigg, and C. Semsarian. 2013. “CCN2 Plays a Key Role in Extracellular Matrix Gene Expression in Severe Hypertrophic Cardiomyopathy and Heart Failure.” Journal of Molecular and Cellular Cardiology 62: 164–178. doi:10.1016/j.yjmcc.2013.05.019.
   PubMed Web of Science ®Google Scholar
• Tsuchida, S., T. Matsuzaki, M. Yamato, K. Okuda, H. Y. Fu, R. Araki, S. Sanada, et al. 2018. “Anti-HB-EGF Antibody-Mediated Delivery of siRNA to Atherosclerotic Lesions in Mice.” International Heart Journal 59 (6): 1425–1431. doi:10.1536/ihj.17-644.
   PubMed Web of Science ®Google Scholar
• Tzahor, E., and K. D. Poss. 2017. “Cardiac Regeneration Strategies: Staying Young at Heart.” Science 356 (6342): 1035–1039. doi:10.1126/science.aam5894.
   PubMed Web of Science ®Google Scholar
• Udell, J. A., D. A. Morrow, P. Jarolim, S. Sloan, E. B. Hoffman, T. F. O’Donnell, A. N. Vora, et al. 2014. “Fibroblast Growth Factor-23, Cardiovascular Prognosis, and Benefit of Angiotensin-Converting Enzyme Inhibition in Stable Ischemic Heart Disease.” Journal of the American College of Cardiology 63 (22): 2421–2428. doi:10.1016/j.jacc.2014.03.026.
   PubMed Web of Science ®Google Scholar
• Vainio, L. E., Z. Szabó, R. Lin, J. Ulvila, R. Yrjölä, T. Alakoski, J. Piuhola, et al. 2019. “Connective Tissue Growth Factor Inhibition Enhances Cardiac Repair and Limits Fibrosis after Myocardial Infarction.” JACC. Basic to Translational Science 4 (1): 83–94. doi:10.1016/j.jacbts.2018.10.007.
   PubMedGoogle Scholar
• Vantler, M., B. C. Karikkineth, H. Naito, M. Tiburcy, M. Didié, M. Nose, S. Rosenkranz, et al. 2010. “PDGF-BB Protects Cardiomyocytes from Apoptosis and Improves Contractile Function of Engineered Heart Tissue.” Journal of Molecular and Cellular Cardiology 48 (6): 1316–1323. doi:10.1016/j.yjmcc.2010.03.008.
   PubMed Web of Science ®Google Scholar
• von Jeinsen, B., K. Sopova, L. Palapies, D. M. Leistner, S. Fichtlscherer, F. H. Seeger, J. Honold, et al. 2019. “Bone Marrow and Plasma FGF-23 in Heart Failure Patients: Novel Insights into the Heart-Bone Axis.” ESC Heart Failure 6 (3): 536–544. doi:10.1002/ehf2.12416.
   PubMed Web of Science ®Google Scholar
• Vujic, A., N. Natarajan, and R. T. Lee. 2020. “Molecular Mechanisms of Heart Regeneration.” Seminars in Cell & Developmental Biology 100: 20–28. doi:10.1016/j.semcdb.2019.09.003.
   PubMed Web of Science ®Google Scholar
• Wang, Y., Q. Huang, J. Liu, Y. Wang, G. Zheng, L. Lin, H. Yu, et al. 2017. “Vascular Endothelial Growth Factor a Polymorphisms Are Associated with Increased Risk of Coronary Heart Disease: A Meta-Analysis.” Oncotarget 8 (18): 30539–30551. doi:10.18632/oncotarget.15546.
   PubMedGoogle Scholar
• Wang, S., Y. Li, C. Jiang, and H. Tian. 2018. “Fibroblast Growth Factor 9 Subfamily and the Heart.” Applied Microbiology and Biotechnology 102 (2): 605–613. doi:10.1007/s00253-017-8652-3.
   PubMed Web of Science ®Google Scholar
• Wang, W., A. Xu, and H. Xu. 2018. “The Roles of Vascular Endothelial Growth Factor Gene Polymorphisms in Congenital Heart Diseases: A Meta-Analysis.” Growth Factors (Chur, Switzerland) 36 (5-6): 232–238. doi:10.1080/08977194.2018.1513505.
   PubMed Web of Science ®Google Scholar
• Watanabe, S., T. Tamura, K. Ono, H. Horiuchi, T. Kimura, T. Kita, and Y. Furukawa. 2010. “Insulin-like Growth Factor Axis (Insulin-like Growth factor-I/Insulin-like Growth Factor-Binding Protein-3) as a Prognostic Predictor of Heart Failure: Association with Adiponectin.” European Journal of Heart Failure 12 (11): 1214–1222. doi:10.1093/eurjhf/hfq166.
   PubMed Web of Science ®Google Scholar
• Weis, S. M., and D. A. Cheresh. 2005. “Pathophysiological Consequences of VEGF-Induced Vascular Permeability.” Nature 437: 497–504.
   PubMed Web of Science ®Google Scholar
• Werner, S., and R. Grose. 2003. “Regulation of Wound Healing by Growth Factors and Cytokines.” Physiological Reviews 83 (3): 835–870. doi:10.1152/physrev.2003.83.3.835.
   PubMed Web of Science ®Google Scholar
• Wohlfahrt, P., V. Melenovsky, M. Kotrc, J. Benes, A. Jabor, J. Franekova, S. Lemaire, et al. 2015. “Association of Fibroblast Growth Factor-23 Levels and Angiotensin-Converting Enzyme Inhibition in Chronic Systolic Heart Failure.” JACC. Heart Failure 3 (10): 829–839. doi:10.1016/j.jchf.2015.05.012.
   PubMed Web of Science ®Google Scholar
• Woitek, F., L. Zentilin, N. E. Hoffman, J. C. Powers, I. Ottiger, S. Parikh, A. M. Kulczycki, et al. 2015. “Intracoronary Cytoprotective Gene Therapy: A Study of VEGF-B167 in a Pre-Clinical Animal Model of Dilated Cardiomyopathy.” Journal of the American College of Cardiology 66 (2): 139–153. doi:10.1016/j.jacc.2015.04.071.
   PubMed Web of Science ®Google Scholar
• Wolf, D., J. Li, and K. Ley. 2015. “HGF Guides T Cells into the Heart.” Immunity 42 (6): 979–981. doi:10.1016/j.immuni.2015.06.001.
   PubMed Web of Science ®Google Scholar
• Wollert, K. C., T. Kempf, and L. Wallentin. 2017. “Growth Differentiation Factor 15 as a Biomarker in Cardiovascular Disease.” Clinical Chemistry 63 (1): 140–151. doi:10.1373/clinchem.2016.255174.
   PubMed Web of Science ®Google Scholar
• Wu, Y. T., K. C. Hsu, T. Y. Li, C. K. Chang, and L. C. Chen. 2018. “Effects of Platelet-Rich Plasma on Pain and Muscle Strength in Patients with Knee Osteoarthritis.” American Journal of Physical Medicine & Rehabilitation 97: 248–254. doi:10.1097/PHM.0000000000000874.
   PubMed Web of Science ®Google Scholar
• Wu, Y., M. S. Kanna, C. Liu, Y. Zhou, and C. K. Chan. 2016. “Generation of Autologous Platelet-Rich Plasma by the Ultrasonic Standing Waves.” IEEE Transactions on Bio-Medical Engineering 63 (8): 1642–1652. doi:10.1109/TBME.2015.2449832.
   PubMed Web of Science ®Google Scholar
• Wu, Q.-Q., Y. Xiao, Y. Yuan, Z.-G. Ma, H.-H. Liao, C. Liu, J.-X. Zhu, Z. Yang, W. Deng, and Q.-Z. Tang. 2017. “Mechanisms Contributing to Cardiac Remodeling.” Clinical Science 131 (18): 2319–2345. doi:10.1042/CS20171167.
   PubMed Web of Science ®Google Scholar
• Wu, H., J. Xie, G.-N. Li, Q.-H. Chen, R. Li, X.-L. Zhang, L.-N. Kang, and B. Xu. 2015. “Possible Involvement of TGF-β/Periostin in Fibrosis of Right Atrial Appendages in Patients with Atrial Fibrillation.” International Journal of Clinical and Experimental Pathology 8 (6): 6859–6869.
   PubMed Web of Science ®Google Scholar
• Xiao, H., H. Lei, S. Qin, K. Ma, and X. Wang. 2010. “TGF-beta1 Expression and Atrial Myocardium Fibrosis Increase in Atrial Fibrillation Secondary to Rheumatic Heart Disease.” Clinical Cardiology 33 (3): 149–156. doi:10.1002/clc.20713.
   PubMed Web of Science ®Google Scholar
• Xu, Y., X. Li, X. Liu, and M. Zhou. 2010. “Neuregulin-1/ErbB Signaling and Chronic Heart Failure.” Advances in Pharmacology 59: 31–51. doi:10.1016/S1054-3589(10)59002-1.
   PubMedGoogle Scholar
• Xu, Z., Z. Tao, Z. Xu, Y. Yang, H. Wang, L. Wang, Z. Wu, et al. 2014. “Cardiac-Specific Expression of the Hepatocyte Growth Factor (HGF) under the Control of a TnIc Promoter Confers a Heart Protective Effect after Myocardial Infarction (MI).” Current Gene Therapy 14 (1): 63–73. doi:10.2174/1566523214666140207104209.
   PubMed Web of Science ®Google Scholar
• Yan, X., and J. P. Morgan. 2011. “Neuregulin1 as Novel Therapy for Heart Failure.” Current Pharmaceutical Design 17 (18): 1808–1817. doi:10.2174/138161211796391010.
   PubMed Web of Science ®Google Scholar
• Yi, X., X. Li, Y. Zhou, S. Ren, W. Wan, G. Feng, and X. Jiang. 2014. “Hepatocyte Growth Factor Regulates the TGF-β1-Induced Proliferation, Differentiation and Secretory Function of Cardiac Fibroblasts.” International Journal of Molecular Medicine 34 (2): 381–390. doi:10.3892/ijmm.2014.1782.
   PubMed Web of Science ®Google Scholar
• Yuan, Z., Y.-H. Tsou, X.-Q. Zhang, S. Huang, Y. Yang, M. Gao, W. Ho, et al. 2019. “Injectable Citrate-Based Hydrogel as an Angiogenic Biomaterial Improves Cardiac Repair after Myocardial Infarction.” ACS Applied Materials & Interfaces 11 (42): 38429–38439. doi:10.1021/acsami.9b12043.
   PubMed Web of Science ®Google Scholar
• Zhang, M., W. W. Ai, Z. L. Mei, Y. H. Hu, and Z. L. Zhang. 2017. “Delivery of Biotinylated IGF-1 with Biotinylated Self-Assembling Peptides Combined with Bone Marrow Stem Cell Transplantation Promotes Cell Therapy for Myocardial Infarction.” Experimental and Therapeutic Medicine 14 (4): 3441–3446. doi:10.3892/etm.2017.4982.
   PubMed Web of Science ®Google Scholar
• Zhang, Y., M. Furumura, and E. Morita. 2008. “Distinct Signaling Pathways Confer Different Vascular Responses to VEGF 121 and VEGF 165.” Growth Factors 26 (3): 125–131. doi:10.1080/08977190802105909.
   PubMed Web of Science ®Google Scholar
• Zhang, D., X. Liu, X. Chen, J. Gu, F. Li, W. Zhang, and Y. Zheng. 2014. “Role of the MAPKs/TGF-β1/TRAF6 Signaling Pathway in Atrial Fibrosis of Patients with Chronic Atrial Fibrillation and Rheumatic Mitral Valve Disease.” Cardiology 129 (4): 216–223. doi:10.1159/000366096.
   PubMed Web of Science ®Google Scholar
• Zeng, F., and C. R. Harris. 2014. “Epidermal Growth Factor, from Gene Organization to Bedside.” Seminars in Cell & Developmental Biology 28: 2–11. doi:10.1016/j.semcdb.2014.01.011.
   PubMed Web of Science ®Google Scholar
• Zhao, Y., S. K. Biswas, P. H. McNulty, M. Kozak, J. Y. Jun, and L. Segar. 2011. “PDGF-Induced Vascular Smooth Muscle Cell Proliferation is Associated with Dysregulation of Insulin Receptor Substrates.” American Journal of Physiology-Cell Physiology 300: 1375–1385. doi:10.1152/ajpcell.00670.2008.
   Web of Science ®Google Scholar
• Zhao, L., X. Liu, Y. Zhang, X. Liang, Y. Ding, Y. Xu, Z. Fang, et al. 2016. “Enhanced Cell Survival and Paracrine Effects of Mesenchymal Stem Cells Overexpressing Hepatocyte Growth Factor Promote Cardioprotection in Myocardial Infarction.” Experimental Cell Research 344 (1): 30–39. doi:10.1016/j.yexcr.2016.03.024.
   PubMed Web of Science ®Google Scholar
• Zhou, X., H. Hu, M. L. Huynh, C. Kotaru, S. Balzar, J. B. Trudeau, and S. E. Wenzel. 2007. “Mechanisms of Tissue Inhibitor of Metalloproteinase 1 Augmentation by IL-13 on TGF-Beta 1-Stimulated Primary Human Fibroblasts.” The Journal of Allergy and Clinical Immunology 119 (6): 1388–1397. doi:10.1016/j.jaci.2007.02.011.
   PubMed Web of Science ®Google Scholar
• Zhu, Z., T. Xu, D. Guo, X. Huangfu, C. Zhong, J. Yang, A. Wang, et al. 2018. “Serum Hepatocyte Growth Factor is Probably Associated with 3-Month Prognosis of Acute Ischemic Stroke.” Stroke 49 (2): 377–383. doi:10.1161/STROKEAHA.117.019476.
   PubMed Web of Science ®Google Scholar
• Zou, J., Q. Fei, H. Xiao, H. Wang, K. Liu, M. Liu, H. Zhang, et al. 2019. “VEGF-A Promotes Angiogenesis after Acute Myocardial Infarction through Increasing ROS Production and Enhancing ER Stress-Mediated Autophagy.” Journal of Cellular Physiology 234 (10): 17690–17703. doi:10.1002/jcp.28395.
   PubMed Web of Science ®Google Scholar